尚高生命科学美股招股说明书(2021-08-24版)

424B5 1 form424b5.htm Filed Pursuant to Rule 424(b)(5)Registration No. 333-250160 Prospectus Supplement(To Prospectus dated June 21, 2021) Shineco, Inc. $10,000,000 of Shares of Common Stock Underlying6% Convertible Promissory Note due 2022 This prospectus supplement covers the issuance of US$10,000,000 worth of our common stock, par value $0.001, issuable to an institutional accredited investor (“Noteholder”) upon the conversion or redemption of US$10,520,000 aggregate principal amount of 6% convertible promissory note (the “Note”) due 2022 and interest accrued thereon. Pursuant to the terms of the securities purchase agreement for the sale and issuance of the Note, we are hereby registering the shares of common stock issuable upon the conversion of the Note for the amount of US$10,000,000. Noteholder may redeem all or any part of the outstanding balance of the Note, at any time after six months from the issue date upon three trading days’ notice, in cash or converting into shares of our common stock at a price equal to 80% multiplied by the lowest daily VWAP during the fifteen (15) trading days immediately preceding the applicable redemption conversion, subject to certain adjustments and ownership limitations specified in the Note. We have the right to prepay all or any portion of the outstanding balance of the Note from Noteholder where the applicable redemption conversion shares have not yet been delivered. If we exercise the right to prepay the Note, we shall make payment to Noteholder of an amount in cash equal to 120% multiplied by the portion of the outstanding balance we elect to prepay. The registration of the issuance of the shares hereunder does not necessarily mean that the Noteholder will convert the Note into common stock. We will not receive any of the proceeds from the issuance of the shares to the Noteholder, but we agreed to pay certain registration expenses relating to the registration of such shares with the U.S. Securities and Exchange Commission, or the SEC. See “Plan of Distribution” elsewhere in this prospectus supplement. Our common stock is listed on the Nasdaq Capital Market under the symbol “TYHT.” On August 23, 2021, the closing price of our common stock was $7.48 per share. The securities offered by this prospectus involve a high degree of risk. See “Risk Factors” beginning on page S-9 of this prospectus supplement and on page 5 of the accompanying prospectus, as well as our other filings that are incorporated by reference into this prospectus supplement and the accompanying prospectus. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense. This prospectus is dated August 24, 2021 Table of Contents PROSPECTUS SUPPLEMENT Page ABOUT THIS PROSPECTUS SUPPLEMENTS-2 WHERE YOU CAN FIND MORE INFORMATION ABOUT USS-3 INCORPORATION OF DOCUMENTS BY REFERENCES-4 SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTSS-5 PROSPECTUS SUPPLEMENT SUMMARYS-6 RISK FACTORSS-9 USE OF PROCEEDSS-11 PLAN OF DISTRIBUTIONS-12 LEGAL MATTERSS-13 EXPERTSS-13 PROSPECTUSPage ABOUT THIS PROSPECTUS2 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS3 ABOUT SHINECO4 RISK FACTORS5 USE OF PROCEEDS6 DESCRIPTION OF SECURITIES TO BE REGISTERED7 PLAN OF DISTRIBUTION17 LEGAL MATTERS19 EXPERTS19 MATERIAL CHANGES19 WHERE YOU CAN FIND ADDITIONAL INFORMATION19 INFORMATION INCORPORATED BY REFERENCE19 You should rely only on the information contained or incorporated by reference in this prospectus or any prospectus supplement. We have not authorized anyone to provide you with information different from that contained or incorporated by reference into this prospectus. If any person does provide you with information that differs from what is contained or incorporated by reference in this prospectus, you should not rely on it. No dealer, salesperson, or other person is authorized to give any information or to represent anything not contained in this prospectus. You should assume that the information contained in this prospectus or any prospectus supplement is accurate only as of the date on the front of the document and that any information contained in any document we have incorporated by reference is accurate only as of the date of the document incorporated by reference, regardless of the time of delivery of this prospectus or any prospectus supplement or any sale of a security. These documents are not an offer to sell or a solicitation of an offer